Form 4: Scientific Industries CFO Acquires Stock Options in Lieu of Cash Compensation

Sentiment:

SEC Form 4 Filing


Reginald Averilla, CFO of Scientific Industries, acquired 9,768 stock options on April 1, 2024, as part of an agreement to receive stock options in lieu of cash compensation.

Summary

  • Reginald Averilla, the CFO of Scientific Industries Inc., acquired 9,768 stock options on April 1, 2024.
  • The options were granted as part of an agreement where Mr. Averilla elected to receive a portion of his salary in stock options instead of cash.
  • The exercise price of the options is $2.50.
  • The options vest in twelve monthly installments starting April 1, 2024, and ending April 1, 2025.
  • The options expire on April 1, 2034.
  • Following the transaction, Mr. Averilla directly owns 29,768 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The CFO taking stock options in lieu of cash suggests confidence, but it's a routine transaction.

Positives

  • The CFO's decision to take stock options in lieu of cash may signal confidence in the company's future performance.
  • The vesting schedule aligns the CFO's interests with the company's performance over the next year.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedule suggests a focus on the company's performance over the next year.

Management Comments

  • Reginald Averilla elected to be paid part of his salary in stock options in lieu of cash compensation.

Industry Context

Stock option grants are a common form of executive compensation, particularly in growth-oriented companies. This aligns executive incentives with shareholder value creation.

Comparison to Industry Standards

  • Executive compensation packages often include a mix of salary, bonus, and equity-based compensation like stock options or restricted stock units (RSUs).
  • The specific mix varies depending on the company's size, industry, and performance.
  • Companies like Tesla, for example, have used stock options extensively to incentivize executives, while more established companies might rely more on cash compensation and RSUs.
  • The vesting schedule of these options, over 12 months, is fairly standard.

Stakeholder Impact

  • Shareholders may view the CFO's decision to take stock options as a positive sign, aligning his interests with theirs.
  • Employees may see this as a sign of confidence in the company's future.

Key Dates

DateDescription
04/01/2024Date of transaction and start of monthly vesting for stock options.
04/01/2025End of monthly vesting period for stock options.
04/01/2034Expiration date of the stock options.
07/01/2024Date of Form 4 signature.

Keywords

stock options, Form 4, CFO, Reginald Averilla, SCND, Scientific Industries, compensation, equity

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.